Chang HR and Pechère JC |
In vitro effects of four macrolides (roxithromycin, spiramycin, azithromycin [CP-62,993], and A-56268) on Toxoplasma gondii. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2837140
|
Barry AL et al. |
In vitro activities of azithromycin (CP 62,993), clarithromycin (A-56268; TE-031), erythromycin, roxithromycin, and clindamycin. |
1988 |
Antimicrob. Agents Chemother. |
pmid:2840016
|
Yourassowsky E et al. |
Rate of bactericidal activity for Branhamella catarrhalis of a new macrolide, CP-62,993, compared with that of amoxicillin-clavulanic acid. |
1988 |
Chemotherapy |
pmid:2843324
|
Retsema J et al. |
Spectrum and mode of action of azithromycin (CP-62,993), a new 15-membered-ring macrolide with improved potency against gram-negative organisms. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2449865
|
Girard AE et al. |
Pharmacokinetic and in vivo studies with azithromycin (CP-62,993), a new macrolide with an extended half-life and excellent tissue distribution. |
1987 |
Antimicrob. Agents Chemother. |
pmid:2830841
|
Walsh M et al. |
In vitro evaluation of CP-62,993, erythromycin, clindamycin, and tetracycline against Chlamydia trachomatis. |
1987 |
Antimicrob. Agents Chemother. |
pmid:3038010
|
Seguà DÃaz M |
[What is the best treatment for urogenital Chlamydia trachomatis infection?] |
|
Semergen |
pmid:27068255
|
Amali A et al. |
Long-term postoperative azithromycin in patients with chronic rhinosinusitis: A randomized clinical trial. |
|
Am J Rhinol Allergy |
pmid:26637580
|
Osman EY et al. |
Analysis of Azithromycin Monohydrate as a Single or a Combinatorial Therapy in a Mouse Model of Severe Spinal Muscular Atrophy. |
|
J Neuromuscul Dis |
pmid:28598854
|
Singh M et al. |
Sunray appearance in lacrimal canaliculitis. |
|
Indian J Pathol Microbiol |
pmid:29676385
|